Wegovy pill safety profile is consistent with GLP-1 medications
Courts require objective medical documentation, including gastric emptying studies, endoscopy findings, and hospitalization records that align with drug exposure dates
These medications undergo rigorous FDA review processes, including Phase I-III clinical trials involving thousands of participants, with ongoing post-marketing surveillance
What to monitor: The same factors as the 1 mg phase, plus blood glucose patterns if you monitor them, hydration status (GLP-1 agonists can reduce thirst cues), and mood or energy shifts that may indicate metabolic transition
We examined the demographic and clinical characteristics of a cohort of MBC survivors, and the occurrence and severity of their physical and psychological symptoms